» Articles » PMID: 19471604

Lack of Association Between P53 Gene Polymorphisms and Primary Open Angle Glaucoma in the Japanese Population

Overview
Journal Mol Vis
Date 2009 May 28
PMID 19471604
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To assess whether tumor protein p53 gene (p53) polymorphisms are associated with primary open angle glaucoma (POAG) in the Japanese population.

Methods: Four hundred and twenty-five Japanese patients with POAG, including normal tension glaucoma (NTG, n=213) and high tension glaucoma (HTG, n=212) and 189 control subjects without glaucoma were analyzed for two p53 polymorphisms (rs1042522; a G-->C substitution at codon 72 in exon 4 and rs59758982; a 16 base pair insertion in intron 3) using allele specific primer PCR and a pyrosequencing technique respectively. The genotypic and allelic frequencies were compared between NTG or HTG patients and control subjects.

Results: No significant difference (NTG versus control, p=0.99, and HTG versus control, p=0.69, chi(2) test) was observed regarding the p53 genotype frequencies at codon 72 between the NTG (GG: 43.2%, GC: 44.6%, CC: 12.2%) or HTG (GG: 40.1%, GC: 48.1%, CC: 11.8%) patients and the control subjects (GG: 43.9%, GC: 43.9%, CC: 12.2%). In addition, there was no significant difference (NTG versus control, p=0.94; and HTG versus control, p=0.66, Fisher's exact test) in the p53 allele frequencies at codon 72 between the NTG (G allele: 65.5%, C allele: 34.5%) or HTG (G allele: 64.2%, C allele: 35.8%) patients and the control subjects (G allele: 65.9%, C allele: 34.1%). No 16 base pair insertion in intron 3 was found in this study.

Conclusion: p53 polymorphisms were not associated with POAG in the Japanese population. Further studies in the other ethnic populations should therefore be performed to elucidate whether the p53 intron 3 insertion polymorphism is a genetic risk factor for POAG, because the intron 3 insertion polymorphism occurs very rarely in the Japanese population.

Citing Articles

Association of Gene Polymorphisms with Normal Tension Glaucoma: A Systematic Review and Meta-Analysis.

Pan L, Wu J, Wang N Genes (Basel). 2024; 15(4).

PMID: 38674425 PMC: 11050218. DOI: 10.3390/genes15040491.


Apoptosis in glaucoma: A new direction for the treatment of glaucoma (Review).

Xia Q, Zhang D Mol Med Rep. 2024; 29(5).

PMID: 38516770 PMC: 10975112. DOI: 10.3892/mmr.2024.13207.


The Role of Mitophagy in Glaucomatous Neurodegeneration.

Stavropoulos D, Grewal M, Petriti B, Chau K, Hammond C, Garway-Heath D Cells. 2023; 12(15).

PMID: 37566048 PMC: 10417839. DOI: 10.3390/cells12151969.


Novel potential drugs for the treatment of primary open-angle glaucoma using protein-protein interaction network analysis.

Zavarzadeh P, Abedi Z Genomics Inform. 2023; 21(1):e6.

PMID: 37037464 PMC: 10085733. DOI: 10.5808/gi.22070.


The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration.

Pietrucha-Dutczak M, Amadio M, Govoni S, Lewin-Kowalik J, Smedowski A Front Neurosci. 2018; 12:834.

PMID: 30524222 PMC: 6262299. DOI: 10.3389/fnins.2018.00834.


References
1.
Dumont P, Leu J, Della Pietra 3rd A, George D, Murphy M . The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003; 33(3):357-65. DOI: 10.1038/ng1093. View

2.
Dimasi D, Hewitt A, Green C, Mackey D, Craig J . Lack of association of p53 polymorphisms and haplotypes in high and normal tension open angle glaucoma. J Med Genet. 2005; 42(9):e55. PMC: 1736135. DOI: 10.1136/jmg.2005.032458. View

3.
Hiyama K, Takeda M, Shirotani Y, Ishioka S, Awaya Y, Inai K . Duplication polymorphism within the third intron of the p53 gene is a rare event in Japanese population. Jpn J Hum Genet. 1994; 39(1):193-5. DOI: 10.1007/BF01915955. View

4.
Acharya M, Mitra S, Mukhopadhyay A, Khan M, Roychoudhury S, Ray K . Distribution of p53 codon 72 polymorphism in Indian primary open angle glaucoma patients. Mol Vis. 2002; 8:367-71. View

5.
Anderson D . Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture. Am J Ophthalmol. 1989; 108(5):485-95. DOI: 10.1016/0002-9394(89)90423-6. View